NEUROFIBROMATOSIS--MOLECULAR-GENETIC APPROACH
NEUROFIBROMATOSIS--MOLECULAR-GENETIC APPROACH
批准号:
3084470
负责人:
Stefan M. PULST
金额:
$8.63万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-09-01 至 1995-08-31
关键词:
DNA RNA achondroplasia alleles autosomal dominant trait chromosome deletion chromosome translocation electrophoresis gel electrophoresis gene expression gene rearrangement genetic disorder diagnosis genetic mapping genetic recombination human genetic material tag human population genetics human subject hybrid cells in situ hybridization karyotype linkage mapping mental retardation messenger RNA molecular pathology neoplastic cell culture for noncancer research neoplastic growth neurofibromatosis nucleic acid hybridization polymerase chain reaction restriction fragment length polymorphism
中文摘要
神经纤维瘤病(NF1)是最常见的一种
英文摘要
Von Recklinghausen-Neurofibromatosis (NF1) is one of the most common
autosomal dominant Mendelian disorders affecting man. It is also the most
common inherited predisposition toward tumor formation in man. The gene for
NF1 has recently been the location further refined by the observation of NF
patients with translocations involving chromosome 17. The study of
patients with chromosome deletions may greatly aid int he identification of
the NF1 gene. These patients are clinically recognized by the occurrence
of several inherited conditions in one individual often accompanied by
mental retardation. Three such patients have been identified. Two
patients are mentally retarded and have a de novo occurrence of NF1 and
achondroplasia (ACH). Because the chance association of these two diseases
would be approximately 1 in 700 million, this suggests that these two
diseases may be caused by a small deletion on chromosome 17. A third
mentally retarded patient has NF1 and a cytogenetically visible deletion of
chromosome 17. The proposed research has four specific aims directed
towards analysis of the NF1 locus: 1) Identification of missing DNA
sequences from patient with putative deletions by quantitative Southern
blotting and pulsed-field gel electrophoresis using single copy DNA
sequences tightly linked to the NF1 locus. 2) Elucidation of possible
mechanisms of tumor formation in tumor cell lines established from NF1
benign and malignant tumors by analysis for loss of chromosomal material
and loss of heterozygosity. 3) Development of novel techniques for
identifying small chromosomal deletions using the analysis of hybrid cell
lines containing a single chromosome 17 with interspersed repeated DNA
sequences. This strategy could have major implications for the analysis of
constitutional or somatic deletions in other diseases, for example NF2. 4)
Molecular analysis of the mutation(s) causing Familial Spinal
Neurofibromatosis by analysis of two families with autosomal dominant
spinal neurofibromas. These families have shown linkage to the NF1 locus
in preliminary studies. The sequence analysis of these mutation(s) may
uniquely contribute to our understanding of tumorigenesis in NF1.
These studies will contribute towards elucidating the molecular basis of
NF1 mutations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ataxin-2 complex proteins in neurodegeneration.
-
批准号:10450573
-
项目类别:
-
资助金额:$93.03万
-
财政年份:2022
-
负责人:Stefan M. PULST
-
依托单位:
Targeting STAU1 for TDP-43 proteinopathies
-
批准号:10512615
-
项目类别:
-
资助金额:$38.37万
-
财政年份:2022
-
负责人:Stefan M. PULST
-
依托单位:
Ataxin-2 complex proteins in neurodegeneration.
-
批准号:10612474
-
项目类别:
-
资助金额:$93.03万
-
财政年份:2022
-
负责人:Stefan M. PULST
-
依托单位:
Antisense Oligonucleotides for treating Spinocerebellar Ataxia Type 2
-
批准号:9912849
-
项目类别:
-
资助金额:$74.37万
-
财政年份:2018
-
负责人:Stefan M. PULST
-
依托单位:
Characterization of ATXN2 as a target for ALS in SCA2 motor neurons
-
批准号:9601486
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2018
-
负责人:Stefan M. PULST
-
依托单位:
Comp B-Western Intermountain Regional NMD STARnet
-
批准号:8915498
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2014
-
负责人:Stefan M. PULST
-
依托单位:
Comp B-Western Intermountain Regional NMD STARnet
-
批准号:8821956
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2014
-
负责人:Stefan M. PULST
-
依托单位:
Identification of mutation causing Purkinje cell degeneration in the shaker rat
-
批准号:8512375
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2013
-
负责人:Stefan M. PULST
-
依托单位:
Antisense oligonucleotides for the treatment of spinocerebellar ataxia type 2
-
批准号:8683274
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2013
-
负责人:Stefan M. PULST
-
依托单位:
Antisense oligonucleotides for the treatment of spinocerebellar ataxia type 2
-
批准号:8584105
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2013
-
负责人:Stefan M. PULST
-
依托单位:
Drug Discovery for Spinocerebellar Ataxia Type 2 (SCA2)
-
批准号:8047349
-
项目类别:
-
资助金额:$83.49万
-
财政年份:2010
-
负责人:Stefan M. PULST
-
依托单位:
Parkin Binders in Progression of Cellular Dysfunction and Death
-
批准号:7119850
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2006
-
负责人:Stefan M. PULST
-
依托单位:
Parkin Interacting Proteins
-
批准号:6970341
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2005
-
负责人:Stefan M. PULST
-
依托单位:
Parkin Interacting Proteins
-
批准号:7140482
-
项目类别:
-
资助金额:$21.14万
-
财政年份:2005
-
负责人:Stefan M. PULST
-
依托单位:
SCA2 GENE AND GENE REPLACEMENT
-
批准号:6416411
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2000
-
负责人:Stefan M. PULST
-
依托单位:
SCA2 GENE AND GENE REPLACEMENT
-
批准号:6306698
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1999
-
负责人:Stefan M. PULST
-
依托单位:
NF2 BINDING PROTEINS
-
批准号:6091674
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1998
-
负责人:Stefan M. PULST
-
依托单位:
NF2 BINDING PROTEINS
-
批准号:2892450
-
项目类别:
-
资助金额:$20.49万
-
财政年份:1998
-
负责人:Stefan M. PULST
-
依托单位:
NF2 BINDING PROTEINS
-
批准号:2687818
-
项目类别:
-
资助金额:$14.05万
-
财政年份:1998
-
负责人:Stefan M. PULST
-
依托单位:
SCA2 GENE AND GENE REPLACEMENT
-
批准号:6117198
-
项目类别:
-
资助金额:$3.89万
-
财政年份:1998
-
负责人:Stefan M. PULST
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: